Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammation()

BACKGROUND: Coronavirus disease 2019 (COVID-19) is associated with an inflammatory cytokine burst and a prothrombotic coagulopathy. Platelets may contribute to microthrombosis, and constitute a therapeutic target in COVID-19 therapy. AIM: To assess if platelet activation influences mortality in COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Philippe, Aurélien, Chocron, Richard, Bonnet, Guillaume, Yatim, Nader, Sutter, Willy, Hadjadj, Jérôme, Weizman, Orianne, Guerin, Coralie L., Mirault, Tristan, Fauvel, Charles, Hauw-Berlemont, Caroline, Samama, Charles-Marc, Terrier, Benjamin, Planquette, Benjamin, Waldmann, Victor, Fontenay, Michaela, Sanchez, Olivier, Diehl, Jean-Luc, Gaussem, Pascale, Cohen, Ariel, Gendron, Nicolas, Smadja, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925415/
https://www.ncbi.nlm.nih.gov/pubmed/36858909
http://dx.doi.org/10.1016/j.acvd.2023.01.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925415/
https://www.ncbi.nlm.nih.gov/pubmed/36858909
http://dx.doi.org/10.1016/j.acvd.2023.01.006

Ejemplares similares